MDM2 Promoter SNP344T>A (rs1196333) Status Does Not Affect Cancer Risk.
Knappskog S, Gansmo LB, Romundstad P, Bjørnslett M, Trovik J, Sommerfelt-Pettersen J, Løkkevik E, for the Norwegian Breast Cancer Group trial NBCG VI, Tollenaar RA, Seynaeve C, et al. PLoS One. 2012; 7(4):e36263. Epub 2012 Apr 30.